Cerep offers a panel of over 630 validated in vitro pharmacological assays that
cover a broad range of targets including receptors, ion channels, transporters, enzymes and second messengers.
These assays are used to identify lead compounds, to define mechanism of action, and to identify off-target activities.
All assays are available on an ad hoc basis. At any time, clients can select one or more assays to be tested against
one or more compounds at one or more concentrations.
In addition to ad hoc access, client specific and Cerep profiles are available. Client specific profiles can be
adapted using any of the over 630 Cerep assays.
Standard Profiles are designed by Cerep and available to all clients.
The Standard Profiles are a rapid and cost effective way of prioritizing the most promising compounds in the
lead selection process.
Benefiting from increased efficiency generated from optimized processes, Cerep is happy to expand custom
made profiles clients can design at set prices. While offering more flexibility, clients are able to select
among predefined lists of functional GPCR, kinase and binding assays.
Cerep is the world leader in Large Scale Profiling
The Cerep profiling platform includes customized robotics optimized for the parallel testing of large libraries of compounds
on broad panels of assays. This approach allows clients to rapidly probe entire target classes. This approach is
an innovative and useful complement to traditional target-by-target HTS.